Metabolomics in detection of Chemotoxicity

Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.

    Related Conference of Metabolomics in detection of Chemotoxicity

    June 21-21, 2021

    4th Forensic Science

    Paris, France
    July 21-21, 2021

    1st Biosimilars

    London, UK
    July 23-23, 2021

    Biofuels and Bioenergy

    Dubai, UAE
    July 26-27, 2021

    5th International Conference on Bioscience and Biotechnology

    London, Aland Islands
    March 15-16, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    July 30-30, 2021

    Glycobiology Biochem Conference 2021

    London, UK
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 24-24, 2021

    27th Asia Pacific Biotechnology Congress

    London, UK
    September 24-24, 2021

    25th World Congress on Pharmaceutical Biotechnology

    London, UK
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland
    November 08-09, 2021

    23rd Global Biotechnology Congress

    Singapore City, Singapore
    December 01-02, 2021

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 03-04, 2021

    International Conference on Biotechnology

    Singapore, Singapore

    Metabolomics in detection of Chemotoxicity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in